CPV Signs Research Agreement With School Of Photovoltaic And Renewable Energy Engineering

With the School of Photovoltaic and Renewable Energy Engineering at UNSW Sydney ClearVue signs 12-month Research Agreement which is to look at the development of a new transparent luminescent solar concentrator using quantum dots. To integrate the developed quantum dot technology with its existing technology and products, if successful ClearVue would seek to scale the prototype further.[optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

UNSW’s School of Photovoltaic and Renewable Energy Engineering under the terms of the binding Research Agreement will carry out contracted research on behalf of ClearVue. Led by Dr. Shujuan Huang and supported by Association will be the research team. Employing quantum dots and demonstrating high quantum yield photoluminescence, the research project will explore the development of a transparent luminescent solar concentrator.

The project includes a milestone development of a small-scale prototype and custom quantum dot materials. To take approximately 12 months from the date of signing the research project is anticipated. ClearVue will seek to scale the prototype in conjunction with UNSW further if the research project is successful, to integrating the developed quantum dot technology with its existing technology and products.

To become an exclusive licensed manufacturer and distributor of ClearVue’s technology and products the company signs MOU with Glass Partners Holdings for territories of South Africa and Mauritius. Situated in most major centers across South Africa with nine facilities conveniently and strategically, Glass Partners is a leading glass processor and supplier in Southern Africa.

Clearvue Technologies Limited (ASX: CPV) traded at a market price of $0.290 down by -0.290% or $0.010 and six months performance has been attractive at around 122.22% but in the last three months have been -54.89%. The market capitalization of the stock is $29.21 million at the current market price. The company is categorized under capital goods.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report